Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine Recombinant Human Insulin Injection in Chinese Diabetes Patients
CTR20140767Phase 3Completed
- Sponsor
- Hefei Tianhui Biotechnology
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of neutral protamine hagedorn in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Hefei Tianhui Biotechnology. Started Dec 2014; status: completed.
02
Drugs
neutral protamine hagedorn
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20140767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140767.